nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—Vinca Alkaloids—Vincristine—kidney cancer	0.26	1	CiPCiCtD
Vinblastine—Vincristine—kidney cancer	0.196	1	CrCtD
Vinblastine—JUN—kidney cancer	0.0747	0.877	CbGaD
Vinblastine—testicular cancer—kidney cancer	0.0727	0.537	CtDrD
Vinblastine—lung cancer—kidney cancer	0.0626	0.463	CtDrD
Vinblastine—Vinorelbine—Vincristine—kidney cancer	0.0459	0.379	CrCrCtD
Vinblastine—Vindesine—Vincristine—kidney cancer	0.0459	0.379	CrCrCtD
Vinblastine—Voacamine—Vincristine—kidney cancer	0.0293	0.242	CrCrCtD
Vinblastine—ABCB1—kidney cancer	0.0105	0.123	CbGaD
Vinblastine—ABCC6—Dactinomycin—kidney cancer	0.00797	0.0543	CbGbCtD
Vinblastine—TUBB2B—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB8—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB6—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB4A—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB2A—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB3—Paclitaxel—kidney cancer	0.0068	0.0463	CbGbCtD
Vinblastine—TUBB8—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB6—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB3—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB4A—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB2B—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB2A—Vincristine—kidney cancer	0.00587	0.04	CbGbCtD
Vinblastine—TUBB—Paclitaxel—kidney cancer	0.00569	0.0388	CbGbCtD
Vinblastine—TUBB1—Paclitaxel—kidney cancer	0.00569	0.0388	CbGbCtD
Vinblastine—TUBB4B—Paclitaxel—kidney cancer	0.00569	0.0388	CbGbCtD
Vinblastine—TUBB4B—Vincristine—kidney cancer	0.00491	0.0334	CbGbCtD
Vinblastine—TUBB1—Vincristine—kidney cancer	0.00491	0.0334	CbGbCtD
Vinblastine—TUBB—Vincristine—kidney cancer	0.00491	0.0334	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—kidney cancer	0.00307	0.0209	CbGbCtD
Vinblastine—ABCB11—Paclitaxel—kidney cancer	0.00236	0.0161	CbGbCtD
Vinblastine—ABCC1—Dactinomycin—kidney cancer	0.00235	0.016	CbGbCtD
Vinblastine—ABCB11—Vincristine—kidney cancer	0.00204	0.0139	CbGbCtD
Vinblastine—ABCC1—Paclitaxel—kidney cancer	0.00168	0.0114	CbGbCtD
Vinblastine—ABCC1—Vincristine—kidney cancer	0.00145	0.00986	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—kidney cancer	0.00127	0.00868	CbGbCtD
Vinblastine—ABCC2—Paclitaxel—kidney cancer	0.00124	0.00846	CbGbCtD
Vinblastine—ABCB1—Temsirolimus—kidney cancer	0.00118	0.00804	CbGbCtD
Vinblastine—CYP2D6—Temsirolimus—kidney cancer	0.00111	0.00758	CbGbCtD
Vinblastine—ABCC2—Sorafenib—kidney cancer	0.0011	0.00752	CbGbCtD
Vinblastine—ABCC2—Vincristine—kidney cancer	0.00107	0.0073	CbGbCtD
Vinblastine—CYP3A4—Everolimus—kidney cancer	0.00105	0.00713	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—kidney cancer	0.000905	0.00616	CbGbCtD
Vinblastine—ABCC2—Sunitinib—kidney cancer	0.000894	0.00609	CbGbCtD
Vinblastine—JUN—nephron—kidney cancer	0.000882	0.0701	CbGeAlD
Vinblastine—SLC22A2—nephron—kidney cancer	0.000758	0.0602	CbGeAlD
Vinblastine—CYP3A4—Temsirolimus—kidney cancer	0.000707	0.00482	CbGbCtD
Vinblastine—ABCC2—Doxorubicin—kidney cancer	0.00067	0.00456	CbGbCtD
Vinblastine—ABCB1—Pazopanib—kidney cancer	0.00062	0.00422	CbGbCtD
Vinblastine—CYP2D6—Pazopanib—kidney cancer	0.000584	0.00398	CbGbCtD
Vinblastine—ABCB1—Dactinomycin—kidney cancer	0.000567	0.00386	CbGbCtD
Vinblastine—ABCB1—Gemcitabine—kidney cancer	0.000448	0.00305	CbGbCtD
Vinblastine—ABCB1—Erlotinib—kidney cancer	0.000442	0.00301	CbGbCtD
Vinblastine—CYP2D6—Erlotinib—kidney cancer	0.000417	0.00284	CbGbCtD
Vinblastine—ABCB1—Paclitaxel—kidney cancer	0.000405	0.00276	CbGbCtD
Vinblastine—CYP3A4—Pazopanib—kidney cancer	0.000372	0.00253	CbGbCtD
Vinblastine—ABCB1—Sorafenib—kidney cancer	0.00036	0.00245	CbGbCtD
Vinblastine—ABCB1—Vincristine—kidney cancer	0.000349	0.00238	CbGbCtD
Vinblastine—CYP2D6—Sorafenib—kidney cancer	0.000339	0.00231	CbGbCtD
Vinblastine—TUBD1—cortex of kidney—kidney cancer	0.000339	0.0269	CbGeAlD
Vinblastine—TUBG1—nephron tubule—kidney cancer	0.000332	0.0264	CbGeAlD
Vinblastine—TUBE1—cortex of kidney—kidney cancer	0.000318	0.0252	CbGeAlD
Vinblastine—TUBE1—gonad—kidney cancer	0.000302	0.024	CbGeAlD
Vinblastine—TUBE1—cardiac atrium—kidney cancer	0.000302	0.024	CbGeAlD
Vinblastine—TUBG1—renal system—kidney cancer	0.000302	0.024	CbGeAlD
Vinblastine—TUBG1—kidney—kidney cancer	0.000292	0.0232	CbGeAlD
Vinblastine—ABCB1—Sunitinib—kidney cancer	0.000291	0.00199	CbGbCtD
Vinblastine—TUBG1—cortex of kidney—kidney cancer	0.000284	0.0226	CbGeAlD
Vinblastine—TUBG1—gonad—kidney cancer	0.000271	0.0215	CbGeAlD
Vinblastine—TUBG1—cardiac atrium—kidney cancer	0.00027	0.0215	CbGeAlD
Vinblastine—CYP3A4—Erlotinib—kidney cancer	0.000265	0.00181	CbGbCtD
Vinblastine—NR5A1—gonad—kidney cancer	0.000264	0.021	CbGeAlD
Vinblastine—CYP3A4—Paclitaxel—kidney cancer	0.000243	0.00165	CbGbCtD
Vinblastine—ABCB1—Doxorubicin—kidney cancer	0.000218	0.00149	CbGbCtD
Vinblastine—CYP3A4—Sorafenib—kidney cancer	0.000216	0.00147	CbGbCtD
Vinblastine—CYP3A4—Vincristine—kidney cancer	0.000209	0.00143	CbGbCtD
Vinblastine—ABCC6—renal system—kidney cancer	0.000207	0.0164	CbGeAlD
Vinblastine—CYP2D6—Doxorubicin—kidney cancer	0.000206	0.0014	CbGbCtD
Vinblastine—ABCC6—kidney—kidney cancer	0.0002	0.0159	CbGeAlD
Vinblastine—CYP3A4—urine—kidney cancer	0.000196	0.0155	CbGeAlD
Vinblastine—CYP2D6—urine—kidney cancer	0.000193	0.0153	CbGeAlD
Vinblastine—TUBA1A—nephron tubule—kidney cancer	0.000192	0.0153	CbGeAlD
Vinblastine—JUN—nephron tubule—kidney cancer	0.00019	0.0151	CbGeAlD
Vinblastine—TUBA1A—renal system—kidney cancer	0.000175	0.0139	CbGeAlD
Vinblastine—CYP3A4—Sunitinib—kidney cancer	0.000175	0.00119	CbGbCtD
Vinblastine—JUN—renal system—kidney cancer	0.000173	0.0138	CbGeAlD
Vinblastine—TUBA1A—kidney—kidney cancer	0.000169	0.0134	CbGeAlD
Vinblastine—JUN—kidney—kidney cancer	0.000167	0.0133	CbGeAlD
Vinblastine—TUBA1A—cortex of kidney—kidney cancer	0.000165	0.0131	CbGeAlD
Vinblastine—SLC22A2—nephron tubule—kidney cancer	0.000164	0.013	CbGeAlD
Vinblastine—JUN—cortex of kidney—kidney cancer	0.000163	0.0129	CbGeAlD
Vinblastine—TUBG1—Sirolimus—Everolimus—kidney cancer	0.000161	0.227	CbGdCrCtD
Vinblastine—TUBG1—Temsirolimus—Everolimus—kidney cancer	0.000161	0.227	CbGdCrCtD
Vinblastine—TUBG1—Sirolimus—Temsirolimus—kidney cancer	0.000161	0.227	CbGdCrCtD
Vinblastine—TUBB2B—nephron tubule—kidney cancer	0.000159	0.0126	CbGeAlD
Vinblastine—TUBA1A—gonad—kidney cancer	0.000157	0.0125	CbGeAlD
Vinblastine—TUBA1A—cardiac atrium—kidney cancer	0.000157	0.0124	CbGeAlD
Vinblastine—JUN—gonad—kidney cancer	0.000155	0.0123	CbGeAlD
Vinblastine—JUN—cardiac atrium—kidney cancer	0.000155	0.0123	CbGeAlD
Vinblastine—TUBB—nephron tubule—kidney cancer	0.00015	0.0119	CbGeAlD
Vinblastine—TUBB2A—nephron tubule—kidney cancer	0.000149	0.0119	CbGeAlD
Vinblastine—TUBB4A—renal system—kidney cancer	0.000149	0.0119	CbGeAlD
Vinblastine—SLC22A2—renal system—kidney cancer	0.000149	0.0118	CbGeAlD
Vinblastine—TUBB6—nephron tubule—kidney cancer	0.000147	0.0117	CbGeAlD
Vinblastine—TUBB4A—kidney—kidney cancer	0.000144	0.0115	CbGeAlD
Vinblastine—TUBB2B—renal system—kidney cancer	0.000144	0.0115	CbGeAlD
Vinblastine—SLC22A2—kidney—kidney cancer	0.000144	0.0114	CbGeAlD
Vinblastine—SLC22A2—cortex of kidney—kidney cancer	0.00014	0.0111	CbGeAlD
Vinblastine—TUBB2B—cortex of kidney—kidney cancer	0.000136	0.0108	CbGeAlD
Vinblastine—TUBB6—renal system—kidney cancer	0.000134	0.0106	CbGeAlD
Vinblastine—TUBB4A—gonad—kidney cancer	0.000134	0.0106	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—kidney cancer	0.000131	0.000891	CbGbCtD
Vinblastine—TUBB6—kidney—kidney cancer	0.00013	0.0103	CbGeAlD
Vinblastine—TUBB2B—gonad—kidney cancer	0.000129	0.0103	CbGeAlD
Vinblastine—TUBB2B—cardiac atrium—kidney cancer	0.000129	0.0103	CbGeAlD
Vinblastine—TUBB—cortex of kidney—kidney cancer	0.000129	0.0102	CbGeAlD
Vinblastine—TUBB4B—nephron tubule—kidney cancer	0.000128	0.0102	CbGeAlD
Vinblastine—TUBB2A—cortex of kidney—kidney cancer	0.000128	0.0102	CbGeAlD
Vinblastine—TUBB6—cortex of kidney—kidney cancer	0.000126	0.01	CbGeAlD
Vinblastine—TUBB—cardiac atrium—kidney cancer	0.000122	0.00972	CbGeAlD
Vinblastine—TUBB2A—cardiac atrium—kidney cancer	0.000122	0.00967	CbGeAlD
Vinblastine—TUBA1A—Zalcitabine—Gemcitabine—kidney cancer	0.00012	0.17	CbGdCrCtD
Vinblastine—TUBB6—gonad—kidney cancer	0.00012	0.00955	CbGeAlD
Vinblastine—TUBB6—cardiac atrium—kidney cancer	0.00012	0.00954	CbGeAlD
Vinblastine—TUBB4B—renal system—kidney cancer	0.000117	0.00926	CbGeAlD
Vinblastine—Voacamine—ABCB1—kidney cancer	0.000115	0.551	CrCbGaD
Vinblastine—TUBB4B—kidney—kidney cancer	0.000113	0.00895	CbGeAlD
Vinblastine—TUBB4B—cortex of kidney—kidney cancer	0.00011	0.00872	CbGeAlD
Vinblastine—TUBB4B—gonad—kidney cancer	0.000104	0.0083	CbGeAlD
Vinblastine—TUBB4B—cardiac atrium—kidney cancer	0.000104	0.00829	CbGeAlD
Vinblastine—ABCC2—nephron tubule—kidney cancer	0.000104	0.00824	CbGeAlD
Vinblastine—ABCC2—renal system—kidney cancer	9.42e-05	0.00749	CbGeAlD
Vinblastine—ABCC2—kidney—kidney cancer	9.11e-05	0.00724	CbGeAlD
Vinblastine—ABCC2—cortex of kidney—kidney cancer	8.87e-05	0.00705	CbGeAlD
Vinblastine—ABCC1—cortex of kidney—kidney cancer	7.82e-05	0.00621	CbGeAlD
Vinblastine—ABCC1—cardiac atrium—kidney cancer	7.43e-05	0.00591	CbGeAlD
Vinblastine—Vinorelbine—ABCB1—kidney cancer	5.35e-05	0.255	CrCbGaD
Vinblastine—CYP3A4—renal system—kidney cancer	4.79e-05	0.0038	CbGeAlD
Vinblastine—CYP2D6—renal system—kidney cancer	4.71e-05	0.00374	CbGeAlD
Vinblastine—TUBB6—Zalcitabine—Gemcitabine—kidney cancer	4.63e-05	0.0655	CbGdCrCtD
Vinblastine—CYP3A4—kidney—kidney cancer	4.63e-05	0.00368	CbGeAlD
Vinblastine—CYP2D6—kidney—kidney cancer	4.55e-05	0.00362	CbGeAlD
Vinblastine—Hypoaesthesia—Vincristine—kidney cancer	4.48e-05	0.00196	CcSEcCtD
Vinblastine—Alopecia—Dactinomycin—kidney cancer	4.45e-05	0.00194	CcSEcCtD
Vinblastine—Anaemia—Sorafenib—kidney cancer	4.45e-05	0.00194	CcSEcCtD
Vinblastine—Agranulocytosis—Gemcitabine—kidney cancer	4.44e-05	0.00194	CcSEcCtD
Vinblastine—Thrombocytopenia—Everolimus—kidney cancer	4.43e-05	0.00194	CcSEcCtD
Vinblastine—Asthenia—Temsirolimus—kidney cancer	4.37e-05	0.00191	CcSEcCtD
Vinblastine—Cerebrovascular accident—Capecitabine—kidney cancer	4.33e-05	0.00189	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—kidney cancer	4.32e-05	0.00188	CcSEcCtD
Vinblastine—Anorexia—Everolimus—kidney cancer	4.32e-05	0.00188	CcSEcCtD
Vinblastine—Leukopenia—Sorafenib—kidney cancer	4.31e-05	0.00188	CcSEcCtD
Vinblastine—Haemoglobin—Gemcitabine—kidney cancer	4.29e-05	0.00187	CcSEcCtD
Vinblastine—Anaemia—Sunitinib—kidney cancer	4.28e-05	0.00187	CcSEcCtD
Vinblastine—Thrombocytopenia—Erlotinib—kidney cancer	4.28e-05	0.00187	CcSEcCtD
Vinblastine—Haemorrhage—Gemcitabine—kidney cancer	4.27e-05	0.00186	CcSEcCtD
Vinblastine—Pancytopenia—Paclitaxel—kidney cancer	4.24e-05	0.00185	CcSEcCtD
Vinblastine—Pharyngitis—Gemcitabine—kidney cancer	4.24e-05	0.00185	CcSEcCtD
Vinblastine—Rectal haemorrhage—Doxorubicin—kidney cancer	4.17e-05	0.00182	CcSEcCtD
Vinblastine—Diarrhoea—Temsirolimus—kidney cancer	4.17e-05	0.00182	CcSEcCtD
Vinblastine—Anorexia—Erlotinib—kidney cancer	4.17e-05	0.00182	CcSEcCtD
Vinblastine—Hypertension—Sorafenib—kidney cancer	4.16e-05	0.00182	CcSEcCtD
Vinblastine—Leukopenia—Sunitinib—kidney cancer	4.15e-05	0.00181	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—kidney cancer	4.14e-05	0.00181	CcSEcCtD
Vinblastine—Asthenia—Pazopanib—kidney cancer	4.12e-05	0.0018	CcSEcCtD
Vinblastine—Ill-defined disorder—Dactinomycin—kidney cancer	4.07e-05	0.00178	CcSEcCtD
Vinblastine—Paraesthesia—Everolimus—kidney cancer	4.07e-05	0.00178	CcSEcCtD
Vinblastine—Anaemia—Dactinomycin—kidney cancer	4.06e-05	0.00177	CcSEcCtD
Vinblastine—Vincristine—ABCB1—kidney cancer	4.05e-05	0.193	CrCbGaD
Vinblastine—Dizziness—Temsirolimus—kidney cancer	4.03e-05	0.00176	CcSEcCtD
Vinblastine—Convulsion—Sunitinib—kidney cancer	4.02e-05	0.00175	CcSEcCtD
Vinblastine—Hypertension—Sunitinib—kidney cancer	4e-05	0.00175	CcSEcCtD
Vinblastine—Alopecia—Vincristine—kidney cancer	3.98e-05	0.00174	CcSEcCtD
Vinblastine—Depression—Paclitaxel—kidney cancer	3.97e-05	0.00173	CcSEcCtD
Vinblastine—Malaise—Dactinomycin—kidney cancer	3.96e-05	0.00173	CcSEcCtD
Vinblastine—Decreased appetite—Everolimus—kidney cancer	3.94e-05	0.00172	CcSEcCtD
Vinblastine—Bone pain—Doxorubicin—kidney cancer	3.93e-05	0.00172	CcSEcCtD
Vinblastine—Acute coronary syndrome—Paclitaxel—kidney cancer	3.93e-05	0.00171	CcSEcCtD
Vinblastine—Leukopenia—Dactinomycin—kidney cancer	3.93e-05	0.00171	CcSEcCtD
Vinblastine—Diarrhoea—Pazopanib—kidney cancer	3.93e-05	0.00171	CcSEcCtD
Vinblastine—Myocardial infarction—Paclitaxel—kidney cancer	3.91e-05	0.0017	CcSEcCtD
Vinblastine—Neuropathy peripheral—Paclitaxel—kidney cancer	3.91e-05	0.0017	CcSEcCtD
Vinblastine—Constipation—Everolimus—kidney cancer	3.87e-05	0.00169	CcSEcCtD
Vinblastine—Pain—Everolimus—kidney cancer	3.87e-05	0.00169	CcSEcCtD
Vinblastine—Vomiting—Temsirolimus—kidney cancer	3.87e-05	0.00169	CcSEcCtD
Vinblastine—Thrombocytopenia—Sorafenib—kidney cancer	3.85e-05	0.00168	CcSEcCtD
Vinblastine—Headache—Temsirolimus—kidney cancer	3.81e-05	0.00166	CcSEcCtD
Vinblastine—Decreased appetite—Erlotinib—kidney cancer	3.8e-05	0.00166	CcSEcCtD
Vinblastine—Dizziness—Pazopanib—kidney cancer	3.79e-05	0.00166	CcSEcCtD
Vinblastine—Alopecia—Gemcitabine—kidney cancer	3.78e-05	0.00165	CcSEcCtD
Vinblastine—Anorexia—Sorafenib—kidney cancer	3.75e-05	0.00164	CcSEcCtD
Vinblastine—Constipation—Erlotinib—kidney cancer	3.74e-05	0.00163	CcSEcCtD
Vinblastine—Pain—Erlotinib—kidney cancer	3.74e-05	0.00163	CcSEcCtD
Vinblastine—Feeling abnormal—Everolimus—kidney cancer	3.73e-05	0.00163	CcSEcCtD
Vinblastine—ABCB1—nephron tubule—kidney cancer	3.73e-05	0.00296	CbGeAlD
Vinblastine—Thrombocytopenia—Sunitinib—kidney cancer	3.7e-05	0.00162	CcSEcCtD
Vinblastine—Gastrointestinal pain—Everolimus—kidney cancer	3.7e-05	0.00162	CcSEcCtD
Vinblastine—Discomfort—Dactinomycin—kidney cancer	3.69e-05	0.00161	CcSEcCtD
Vinblastine—Vomiting—Pazopanib—kidney cancer	3.65e-05	0.00159	CcSEcCtD
Vinblastine—Anaemia—Vincristine—kidney cancer	3.62e-05	0.00158	CcSEcCtD
Vinblastine—Nausea—Temsirolimus—kidney cancer	3.62e-05	0.00158	CcSEcCtD
Vinblastine—Anorexia—Sunitinib—kidney cancer	3.61e-05	0.00157	CcSEcCtD
Vinblastine—Haemoglobin—Paclitaxel—kidney cancer	3.6e-05	0.00157	CcSEcCtD
Vinblastine—Headache—Pazopanib—kidney cancer	3.59e-05	0.00157	CcSEcCtD
Vinblastine—Abdominal pain—Everolimus—kidney cancer	3.58e-05	0.00156	CcSEcCtD
Vinblastine—Haemorrhage—Paclitaxel—kidney cancer	3.58e-05	0.00156	CcSEcCtD
Vinblastine—Gastrointestinal pain—Erlotinib—kidney cancer	3.57e-05	0.00156	CcSEcCtD
Vinblastine—Angina pectoris—Capecitabine—kidney cancer	3.57e-05	0.00156	CcSEcCtD
Vinblastine—Hypoaesthesia—Paclitaxel—kidney cancer	3.56e-05	0.00155	CcSEcCtD
Vinblastine—Pharyngitis—Paclitaxel—kidney cancer	3.55e-05	0.00155	CcSEcCtD
Vinblastine—Vertigo—Vincristine—kidney cancer	3.52e-05	0.00154	CcSEcCtD
Vinblastine—Leukopenia—Vincristine—kidney cancer	3.51e-05	0.00153	CcSEcCtD
Vinblastine—Thrombocytopenia—Dactinomycin—kidney cancer	3.51e-05	0.00153	CcSEcCtD
Vinblastine—Pancytopenia—Capecitabine—kidney cancer	3.48e-05	0.00152	CcSEcCtD
Vinblastine—Abdominal pain—Erlotinib—kidney cancer	3.45e-05	0.00151	CcSEcCtD
Vinblastine—Ill-defined disorder—Gemcitabine—kidney cancer	3.45e-05	0.00151	CcSEcCtD
Vinblastine—Anaemia—Gemcitabine—kidney cancer	3.44e-05	0.0015	CcSEcCtD
Vinblastine—Decreased appetite—Sorafenib—kidney cancer	3.42e-05	0.00149	CcSEcCtD
Vinblastine—Anorexia—Dactinomycin—kidney cancer	3.41e-05	0.00149	CcSEcCtD
Vinblastine—Nausea—Pazopanib—kidney cancer	3.41e-05	0.00149	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—kidney cancer	3.41e-05	0.00149	CcSEcCtD
Vinblastine—Paraesthesia—Sunitinib—kidney cancer	3.4e-05	0.00148	CcSEcCtD
Vinblastine—Convulsion—Vincristine—kidney cancer	3.4e-05	0.00148	CcSEcCtD
Vinblastine—ABCB1—renal system—kidney cancer	3.39e-05	0.00269	CbGeAlD
Vinblastine—Hypertension—Vincristine—kidney cancer	3.39e-05	0.00148	CcSEcCtD
Vinblastine—Constipation—Sorafenib—kidney cancer	3.36e-05	0.00147	CcSEcCtD
Vinblastine—Pain—Sorafenib—kidney cancer	3.36e-05	0.00147	CcSEcCtD
Vinblastine—Malaise—Gemcitabine—kidney cancer	3.35e-05	0.00146	CcSEcCtD
Vinblastine—Hypersensitivity—Everolimus—kidney cancer	3.34e-05	0.00146	CcSEcCtD
Vinblastine—Leukopenia—Gemcitabine—kidney cancer	3.33e-05	0.00145	CcSEcCtD
Vinblastine—Decreased appetite—Sunitinib—kidney cancer	3.29e-05	0.00144	CcSEcCtD
Vinblastine—ABCB1—kidney—kidney cancer	3.28e-05	0.0026	CbGeAlD
Vinblastine—Depression—Capecitabine—kidney cancer	3.26e-05	0.00142	CcSEcCtD
Vinblastine—Asthenia—Everolimus—kidney cancer	3.25e-05	0.00142	CcSEcCtD
Vinblastine—Constipation—Sunitinib—kidney cancer	3.24e-05	0.00141	CcSEcCtD
Vinblastine—Pain—Sunitinib—kidney cancer	3.24e-05	0.00141	CcSEcCtD
Vinblastine—Acute coronary syndrome—Capecitabine—kidney cancer	3.22e-05	0.00141	CcSEcCtD
Vinblastine—Gastrointestinal pain—Sorafenib—kidney cancer	3.22e-05	0.0014	CcSEcCtD
Vinblastine—Hypertension—Gemcitabine—kidney cancer	3.21e-05	0.0014	CcSEcCtD
Vinblastine—Myocardial infarction—Capecitabine—kidney cancer	3.21e-05	0.0014	CcSEcCtD
Vinblastine—Neuropathy peripheral—Capecitabine—kidney cancer	3.21e-05	0.0014	CcSEcCtD
Vinblastine—ABCB1—cortex of kidney—kidney cancer	3.19e-05	0.00253	CbGeAlD
Vinblastine—Phlebitis—Doxorubicin—kidney cancer	3.18e-05	0.00139	CcSEcCtD
Vinblastine—Alopecia—Paclitaxel—kidney cancer	3.16e-05	0.00138	CcSEcCtD
Vinblastine—Asthenia—Erlotinib—kidney cancer	3.14e-05	0.00137	CcSEcCtD
Vinblastine—Thrombocytopenia—Vincristine—kidney cancer	3.13e-05	0.00137	CcSEcCtD
Vinblastine—Discomfort—Gemcitabine—kidney cancer	3.13e-05	0.00137	CcSEcCtD
Vinblastine—Decreased appetite—Dactinomycin—kidney cancer	3.11e-05	0.00136	CcSEcCtD
Vinblastine—Abdominal pain—Sorafenib—kidney cancer	3.11e-05	0.00136	CcSEcCtD
Vinblastine—Diarrhoea—Everolimus—kidney cancer	3.1e-05	0.00135	CcSEcCtD
Vinblastine—Gastrointestinal pain—Sunitinib—kidney cancer	3.09e-05	0.00135	CcSEcCtD
Vinblastine—Pain—Dactinomycin—kidney cancer	3.06e-05	0.00134	CcSEcCtD
Vinblastine—Agranulocytosis—Capecitabine—kidney cancer	3.05e-05	0.00133	CcSEcCtD
Vinblastine—Anorexia—Vincristine—kidney cancer	3.05e-05	0.00133	CcSEcCtD
Vinblastine—ABCB1—gonad—kidney cancer	3.04e-05	0.00241	CbGeAlD
Vinblastine—Dizziness—Everolimus—kidney cancer	3e-05	0.00131	CcSEcCtD
Vinblastine—Abdominal pain—Sunitinib—kidney cancer	2.99e-05	0.00131	CcSEcCtD
Vinblastine—Diarrhoea—Erlotinib—kidney cancer	2.99e-05	0.00131	CcSEcCtD
Vinblastine—Thrombocytopenia—Gemcitabine—kidney cancer	2.97e-05	0.0013	CcSEcCtD
Vinblastine—Feeling abnormal—Dactinomycin—kidney cancer	2.95e-05	0.00129	CcSEcCtD
Vinblastine—Haemoglobin—Capecitabine—kidney cancer	2.95e-05	0.00129	CcSEcCtD
Vinblastine—Haemorrhage—Capecitabine—kidney cancer	2.94e-05	0.00128	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dactinomycin—kidney cancer	2.93e-05	0.00128	CcSEcCtD
Vinblastine—Hypoaesthesia—Capecitabine—kidney cancer	2.92e-05	0.00127	CcSEcCtD
Vinblastine—Pharyngitis—Capecitabine—kidney cancer	2.91e-05	0.00127	CcSEcCtD
Vinblastine—Hypersensitivity—Sorafenib—kidney cancer	2.9e-05	0.00126	CcSEcCtD
Vinblastine—Anorexia—Gemcitabine—kidney cancer	2.89e-05	0.00126	CcSEcCtD
Vinblastine—Dizziness—Erlotinib—kidney cancer	2.89e-05	0.00126	CcSEcCtD
Vinblastine—Ill-defined disorder—Paclitaxel—kidney cancer	2.89e-05	0.00126	CcSEcCtD
Vinblastine—Vomiting—Everolimus—kidney cancer	2.88e-05	0.00126	CcSEcCtD
Vinblastine—Anaemia—Paclitaxel—kidney cancer	2.88e-05	0.00126	CcSEcCtD
Vinblastine—Paraesthesia—Vincristine—kidney cancer	2.87e-05	0.00125	CcSEcCtD
Vinblastine—Headache—Everolimus—kidney cancer	2.84e-05	0.00124	CcSEcCtD
Vinblastine—Abdominal pain—Dactinomycin—kidney cancer	2.83e-05	0.00124	CcSEcCtD
Vinblastine—Asthenia—Sorafenib—kidney cancer	2.82e-05	0.00123	CcSEcCtD
Vinblastine—Malaise—Paclitaxel—kidney cancer	2.81e-05	0.00123	CcSEcCtD
Vinblastine—Vertigo—Paclitaxel—kidney cancer	2.8e-05	0.00122	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—kidney cancer	2.79e-05	0.00122	CcSEcCtD
Vinblastine—Leukopenia—Paclitaxel—kidney cancer	2.79e-05	0.00122	CcSEcCtD
Vinblastine—Hypersensitivity—Sunitinib—kidney cancer	2.79e-05	0.00122	CcSEcCtD
Vinblastine—Decreased appetite—Vincristine—kidney cancer	2.78e-05	0.00121	CcSEcCtD
Vinblastine—Vomiting—Erlotinib—kidney cancer	2.78e-05	0.00121	CcSEcCtD
Vinblastine—Headache—Erlotinib—kidney cancer	2.74e-05	0.00119	CcSEcCtD
Vinblastine—Constipation—Vincristine—kidney cancer	2.74e-05	0.00119	CcSEcCtD
Vinblastine—Pain—Vincristine—kidney cancer	2.74e-05	0.00119	CcSEcCtD
Vinblastine—Paraesthesia—Gemcitabine—kidney cancer	2.73e-05	0.00119	CcSEcCtD
Vinblastine—Asthenia—Sunitinib—kidney cancer	2.71e-05	0.00118	CcSEcCtD
Vinblastine—Convulsion—Paclitaxel—kidney cancer	2.7e-05	0.00118	CcSEcCtD
Vinblastine—Nausea—Everolimus—kidney cancer	2.69e-05	0.00117	CcSEcCtD
Vinblastine—Diarrhoea—Sorafenib—kidney cancer	2.69e-05	0.00117	CcSEcCtD
Vinblastine—Hypertension—Paclitaxel—kidney cancer	2.69e-05	0.00117	CcSEcCtD
Vinblastine—Decreased appetite—Gemcitabine—kidney cancer	2.64e-05	0.00115	CcSEcCtD
Vinblastine—Hypersensitivity—Dactinomycin—kidney cancer	2.64e-05	0.00115	CcSEcCtD
Vinblastine—Discomfort—Paclitaxel—kidney cancer	2.62e-05	0.00114	CcSEcCtD
Vinblastine—Gastrointestinal pain—Vincristine—kidney cancer	2.62e-05	0.00114	CcSEcCtD
Vinblastine—Dizziness—Sorafenib—kidney cancer	2.6e-05	0.00113	CcSEcCtD
Vinblastine—Pain—Gemcitabine—kidney cancer	2.6e-05	0.00113	CcSEcCtD
Vinblastine—Constipation—Gemcitabine—kidney cancer	2.6e-05	0.00113	CcSEcCtD
Vinblastine—Nausea—Erlotinib—kidney cancer	2.6e-05	0.00113	CcSEcCtD
Vinblastine—Alopecia—Capecitabine—kidney cancer	2.59e-05	0.00113	CcSEcCtD
Vinblastine—Diarrhoea—Sunitinib—kidney cancer	2.59e-05	0.00113	CcSEcCtD
Vinblastine—Asthenia—Dactinomycin—kidney cancer	2.57e-05	0.00112	CcSEcCtD
Vinblastine—Abdominal pain—Vincristine—kidney cancer	2.53e-05	0.0011	CcSEcCtD
Vinblastine—TUBA1A—Azacitidine—Gemcitabine—kidney cancer	2.53e-05	0.0358	CbGdCrCtD
Vinblastine—Dizziness—Sunitinib—kidney cancer	2.5e-05	0.00109	CcSEcCtD
Vinblastine—Feeling abnormal—Gemcitabine—kidney cancer	2.5e-05	0.00109	CcSEcCtD
Vinblastine—Vomiting—Sorafenib—kidney cancer	2.5e-05	0.00109	CcSEcCtD
Vinblastine—Thrombocytopenia—Paclitaxel—kidney cancer	2.49e-05	0.00109	CcSEcCtD
Vinblastine—Headache—Sorafenib—kidney cancer	2.46e-05	0.00107	CcSEcCtD
Vinblastine—Diarrhoea—Dactinomycin—kidney cancer	2.45e-05	0.00107	CcSEcCtD
Vinblastine—Anorexia—Paclitaxel—kidney cancer	2.42e-05	0.00106	CcSEcCtD
Vinblastine—Vomiting—Sunitinib—kidney cancer	2.41e-05	0.00105	CcSEcCtD
Vinblastine—Ill-defined disorder—Capecitabine—kidney cancer	2.37e-05	0.00103	CcSEcCtD
Vinblastine—Headache—Sunitinib—kidney cancer	2.37e-05	0.00103	CcSEcCtD
Vinblastine—Anaemia—Capecitabine—kidney cancer	2.36e-05	0.00103	CcSEcCtD
Vinblastine—Hypersensitivity—Vincristine—kidney cancer	2.36e-05	0.00103	CcSEcCtD
Vinblastine—TUBB—Azacitidine—Gemcitabine—kidney cancer	2.36e-05	0.0333	CbGdCrCtD
Vinblastine—Nausea—Sorafenib—kidney cancer	2.34e-05	0.00102	CcSEcCtD
Vinblastine—Malaise—Capecitabine—kidney cancer	2.3e-05	0.00101	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—kidney cancer	2.3e-05	0.00101	CcSEcCtD
Vinblastine—Vertigo—Capecitabine—kidney cancer	2.3e-05	0.001	CcSEcCtD
Vinblastine—Asthenia—Vincristine—kidney cancer	2.3e-05	0.001	CcSEcCtD
Vinblastine—Leukopenia—Capecitabine—kidney cancer	2.29e-05	0.000998	CcSEcCtD
Vinblastine—Paraesthesia—Paclitaxel—kidney cancer	2.28e-05	0.000996	CcSEcCtD
Vinblastine—Vomiting—Dactinomycin—kidney cancer	2.28e-05	0.000994	CcSEcCtD
Vinblastine—Nausea—Sunitinib—kidney cancer	2.25e-05	0.000981	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—kidney cancer	2.25e-05	0.00098	CcSEcCtD
Vinblastine—Decreased appetite—Paclitaxel—kidney cancer	2.21e-05	0.000964	CcSEcCtD
Vinblastine—Hypertension—Capecitabine—kidney cancer	2.21e-05	0.000963	CcSEcCtD
Vinblastine—Diarrhoea—Vincristine—kidney cancer	2.19e-05	0.000956	CcSEcCtD
Vinblastine—Asthenia—Gemcitabine—kidney cancer	2.18e-05	0.000951	CcSEcCtD
Vinblastine—Pain—Paclitaxel—kidney cancer	2.17e-05	0.000949	CcSEcCtD
Vinblastine—Constipation—Paclitaxel—kidney cancer	2.17e-05	0.000949	CcSEcCtD
Vinblastine—Discomfort—Capecitabine—kidney cancer	2.15e-05	0.000938	CcSEcCtD
Vinblastine—Nausea—Dactinomycin—kidney cancer	2.13e-05	0.000928	CcSEcCtD
Vinblastine—Dizziness—Vincristine—kidney cancer	2.12e-05	0.000924	CcSEcCtD
Vinblastine—Feeling abnormal—Paclitaxel—kidney cancer	2.09e-05	0.000914	CcSEcCtD
Vinblastine—Gastrointestinal pain—Paclitaxel—kidney cancer	2.08e-05	0.000907	CcSEcCtD
Vinblastine—Diarrhoea—Gemcitabine—kidney cancer	2.08e-05	0.000906	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—kidney cancer	2.07e-05	0.000902	CcSEcCtD
Vinblastine—Thrombocytopenia—Capecitabine—kidney cancer	2.04e-05	0.000891	CcSEcCtD
Vinblastine—Vomiting—Vincristine—kidney cancer	2.03e-05	0.000888	CcSEcCtD
Vinblastine—Abdominal pain—Paclitaxel—kidney cancer	2.01e-05	0.000877	CcSEcCtD
Vinblastine—Headache—Vincristine—kidney cancer	2e-05	0.000875	CcSEcCtD
Vinblastine—Anorexia—Capecitabine—kidney cancer	1.99e-05	0.000868	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—kidney cancer	1.97e-05	0.000859	CcSEcCtD
Vinblastine—Vomiting—Gemcitabine—kidney cancer	1.93e-05	0.000842	CcSEcCtD
Vinblastine—Haemoglobin—Doxorubicin—kidney cancer	1.9e-05	0.00083	CcSEcCtD
Vinblastine—Headache—Gemcitabine—kidney cancer	1.9e-05	0.00083	CcSEcCtD
Vinblastine—Nausea—Vincristine—kidney cancer	1.9e-05	0.00083	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—kidney cancer	1.89e-05	0.000826	CcSEcCtD
Vinblastine—Hypoaesthesia—Doxorubicin—kidney cancer	1.88e-05	0.000822	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—kidney cancer	1.88e-05	0.00082	CcSEcCtD
Vinblastine—Paraesthesia—Capecitabine—kidney cancer	1.87e-05	0.000817	CcSEcCtD
Vinblastine—Hypersensitivity—Paclitaxel—kidney cancer	1.87e-05	0.000817	CcSEcCtD
Vinblastine—Asthenia—Paclitaxel—kidney cancer	1.82e-05	0.000796	CcSEcCtD
Vinblastine—Decreased appetite—Capecitabine—kidney cancer	1.81e-05	0.000791	CcSEcCtD
Vinblastine—Nausea—Gemcitabine—kidney cancer	1.8e-05	0.000787	CcSEcCtD
Vinblastine—Pain—Capecitabine—kidney cancer	1.78e-05	0.000778	CcSEcCtD
Vinblastine—Constipation—Capecitabine—kidney cancer	1.78e-05	0.000778	CcSEcCtD
Vinblastine—Diarrhoea—Paclitaxel—kidney cancer	1.74e-05	0.000759	CcSEcCtD
Vinblastine—Feeling abnormal—Capecitabine—kidney cancer	1.72e-05	0.00075	CcSEcCtD
Vinblastine—Gastrointestinal pain—Capecitabine—kidney cancer	1.71e-05	0.000744	CcSEcCtD
Vinblastine—Dizziness—Paclitaxel—kidney cancer	1.68e-05	0.000734	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—kidney cancer	1.67e-05	0.00073	CcSEcCtD
Vinblastine—Abdominal pain—Capecitabine—kidney cancer	1.65e-05	0.00072	CcSEcCtD
Vinblastine—Vomiting—Paclitaxel—kidney cancer	1.62e-05	0.000705	CcSEcCtD
Vinblastine—Headache—Paclitaxel—kidney cancer	1.59e-05	0.000695	CcSEcCtD
Vinblastine—Hypersensitivity—Capecitabine—kidney cancer	1.54e-05	0.000671	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—kidney cancer	1.53e-05	0.000667	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—kidney cancer	1.52e-05	0.000665	CcSEcCtD
Vinblastine—Nausea—Paclitaxel—kidney cancer	1.51e-05	0.000659	CcSEcCtD
Vinblastine—Asthenia—Capecitabine—kidney cancer	1.5e-05	0.000653	CcSEcCtD
Vinblastine—Malaise—Doxorubicin—kidney cancer	1.49e-05	0.000648	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—kidney cancer	1.48e-05	0.000646	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—kidney cancer	1.47e-05	0.000644	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—kidney cancer	1.43e-05	0.000623	CcSEcCtD
Vinblastine—Diarrhoea—Capecitabine—kidney cancer	1.43e-05	0.000623	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—kidney cancer	1.42e-05	0.000621	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—kidney cancer	1.39e-05	0.000605	CcSEcCtD
Vinblastine—Dizziness—Capecitabine—kidney cancer	1.38e-05	0.000602	CcSEcCtD
Vinblastine—Vomiting—Capecitabine—kidney cancer	1.33e-05	0.000579	CcSEcCtD
Vinblastine—Thrombocytopenia—Doxorubicin—kidney cancer	1.32e-05	0.000575	CcSEcCtD
Vinblastine—Headache—Capecitabine—kidney cancer	1.31e-05	0.00057	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—kidney cancer	1.28e-05	0.000559	CcSEcCtD
Vinblastine—Nausea—Capecitabine—kidney cancer	1.24e-05	0.000541	CcSEcCtD
Vinblastine—Paraesthesia—Doxorubicin—kidney cancer	1.21e-05	0.000527	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—kidney cancer	1.17e-05	0.00051	CcSEcCtD
Vinblastine—Pain—Doxorubicin—kidney cancer	1.15e-05	0.000502	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—kidney cancer	1.15e-05	0.000502	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—kidney cancer	1.11e-05	0.000484	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—kidney cancer	1.1e-05	0.00048	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—kidney cancer	1.06e-05	0.000464	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—kidney cancer	9.91e-06	0.000432	CcSEcCtD
Vinblastine—TUBB6—Azacitidine—Gemcitabine—kidney cancer	9.74e-06	0.0138	CbGdCrCtD
Vinblastine—Asthenia—Doxorubicin—kidney cancer	9.65e-06	0.000421	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—kidney cancer	9.2e-06	0.000401	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—kidney cancer	8.89e-06	0.000388	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—kidney cancer	8.55e-06	0.000373	CcSEcCtD
Vinblastine—Headache—Doxorubicin—kidney cancer	8.42e-06	0.000368	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—kidney cancer	7.99e-06	0.000349	CcSEcCtD
Vinblastine—ABCC1—Metabolism—ACHE—kidney cancer	1.67e-06	8.68e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTT1—kidney cancer	1.67e-06	8.68e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—RAF1—kidney cancer	1.67e-06	8.66e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—RELA—kidney cancer	1.66e-06	8.63e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SLC2A1—kidney cancer	1.66e-06	8.61e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—ERBB2—kidney cancer	1.65e-06	8.57e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD8A—kidney cancer	1.65e-06	8.56e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—JUNB—kidney cancer	1.65e-06	8.55e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CTNNB1—kidney cancer	1.63e-06	8.47e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK3—kidney cancer	1.63e-06	8.46e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MTOR—kidney cancer	1.63e-06	8.46e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CD4—kidney cancer	1.63e-06	8.44e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPAT—kidney cancer	1.61e-06	8.38e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.61e-06	8.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ITPR2—kidney cancer	1.6e-06	8.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—FH—kidney cancer	1.59e-06	8.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APRT—kidney cancer	1.59e-06	8.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.59e-06	8.24e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MYC—kidney cancer	1.59e-06	8.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SCARB1—kidney cancer	1.58e-06	8.22e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.57e-06	8.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS1—kidney cancer	1.57e-06	8.13e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.56e-06	8.12e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PSMD7—kidney cancer	1.56e-06	8.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSC1—kidney cancer	1.56e-06	8.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ANXA1—kidney cancer	1.56e-06	8.08e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK1—kidney cancer	1.55e-06	8.05e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GSTP1—kidney cancer	1.54e-06	8.01e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PSMD7—kidney cancer	1.54e-06	7.98e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.54e-06	7.97e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CDKN1B—kidney cancer	1.53e-06	7.94e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACY1—kidney cancer	1.52e-06	7.9e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FLT1—kidney cancer	1.51e-06	7.82e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FH—kidney cancer	1.5e-06	7.79e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APRT—kidney cancer	1.5e-06	7.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPC3—kidney cancer	1.5e-06	7.77e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—MAPK1—kidney cancer	1.47e-06	7.64e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.46e-06	7.59e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ABCB1—kidney cancer	1.46e-06	7.58e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—BCHE—kidney cancer	1.46e-06	7.56e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CA2—kidney cancer	1.46e-06	7.56e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ACHE—kidney cancer	1.46e-06	7.56e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTT1—kidney cancer	1.46e-06	7.56e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.45e-06	7.55e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CTNNB1—kidney cancer	1.44e-06	7.5e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SLC5A5—kidney cancer	1.44e-06	7.47e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—kidney cancer	1.42e-06	7.39e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALAD—kidney cancer	1.42e-06	7.37e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GSTM1—kidney cancer	1.42e-06	7.36e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.41e-06	7.33e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPC3—kidney cancer	1.41e-06	7.32e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PTEN—kidney cancer	1.41e-06	7.31e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—TSC2—kidney cancer	1.4e-06	7.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—JUNB—kidney cancer	1.4e-06	7.25e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PAK1—kidney cancer	1.4e-06	7.25e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SLC2A1—kidney cancer	1.39e-06	7.21e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.39e-06	7.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.38e-06	7.19e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.38e-06	7.19e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SCARB1—kidney cancer	1.38e-06	7.15e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.37e-06	7.13e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CA2—kidney cancer	1.37e-06	7.12e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS1—kidney cancer	1.36e-06	7.08e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.35e-06	7.03e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.35e-06	7e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP1A1—kidney cancer	1.34e-06	6.98e-05	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.34e-06	6.96e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN2B—kidney cancer	1.34e-06	6.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.34e-06	6.95e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PSMD7—kidney cancer	1.34e-06	6.95e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALAD—kidney cancer	1.34e-06	6.94e-05	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.32e-06	6.88e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.3e-06	6.77e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—kidney cancer	1.3e-06	6.76e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A3—kidney cancer	1.3e-06	6.74e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PGK1—kidney cancer	1.3e-06	6.74e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PDHB—kidney cancer	1.29e-06	6.72e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.29e-06	6.7e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.28e-06	6.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LDHB—kidney cancer	1.27e-06	6.61e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—BCHE—kidney cancer	1.27e-06	6.58e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.25e-06	6.5e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KIT—kidney cancer	1.24e-06	6.43e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.22e-06	6.35e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PGK1—kidney cancer	1.22e-06	6.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.22e-06	6.32e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.21e-06	6.28e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.21e-06	6.28e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK3—kidney cancer	1.2e-06	6.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LDHB—kidney cancer	1.2e-06	6.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.18e-06	6.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTP1—kidney cancer	1.16e-06	6.02e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.15e-06	5.99e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK1—kidney cancer	1.14e-06	5.94e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.14e-06	5.94e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF2—kidney cancer	1.14e-06	5.93e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—kidney cancer	1.14e-06	5.92e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN2B—kidney cancer	1.14e-06	5.9e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.11e-06	5.78e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1R—kidney cancer	1.1e-06	5.73e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.1e-06	5.73e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CA9—kidney cancer	1.1e-06	5.73e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ABCB1—kidney cancer	1.1e-06	5.69e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.09e-06	5.65e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—kidney cancer	1.08e-06	5.61e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HIF1A—kidney cancer	1.07e-06	5.56e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TSC2—kidney cancer	1.07e-06	5.55e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTM1—kidney cancer	1.06e-06	5.53e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.05e-06	5.48e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPAT—kidney cancer	1.05e-06	5.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CA9—kidney cancer	1.04e-06	5.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.03e-06	5.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP1A1—kidney cancer	1.01e-06	5.24e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTP1—kidney cancer	1.01e-06	5.24e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—POMC—kidney cancer	1e-06	5.2e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CA—kidney cancer	9.93e-07	5.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FH—kidney cancer	9.8e-07	5.09e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APRT—kidney cancer	9.8e-07	5.09e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—RAF1—kidney cancer	9.72e-07	5.05e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—RELA—kidney cancer	9.67e-07	5.02e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERBB2—kidney cancer	9.61e-07	4.99e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ABCB1—kidney cancer	9.55e-07	4.96e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MTOR—kidney cancer	9.49e-07	4.93e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—kidney cancer	9.47e-07	4.92e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.45e-07	4.91e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APC—kidney cancer	9.44e-07	4.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KIT—kidney cancer	9.44e-07	4.9e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CRABP1—kidney cancer	9.38e-07	4.87e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—kidney cancer	9.27e-07	4.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPC3—kidney cancer	9.22e-07	4.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.14e-07	4.75e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HIF1A—kidney cancer	9.09e-07	4.72e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TSC2—kidney cancer	9.06e-07	4.71e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CA2—kidney cancer	8.97e-07	4.66e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1B—kidney cancer	8.9e-07	4.62e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—kidney cancer	8.87e-07	4.61e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CRABP1—kidney cancer	8.84e-07	4.59e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP1A1—kidney cancer	8.79e-07	4.56e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALAD—kidney cancer	8.74e-07	4.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ITPR2—kidney cancer	8.72e-07	4.53e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—kidney cancer	8.71e-07	4.52e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KDR—kidney cancer	8.69e-07	4.51e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.53e-07	4.43e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTNNB1—kidney cancer	8.41e-07	4.37e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.34e-07	4.33e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.29e-07	4.31e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ITPR2—kidney cancer	8.22e-07	4.27e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—kidney cancer	8.2e-07	4.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIT—kidney cancer	8e-07	4.16e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APC—kidney cancer	8e-07	4.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PGK1—kidney cancer	7.99e-07	4.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.99e-07	4.15e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—kidney cancer	7.99e-07	4.15e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTT1—kidney cancer	7.95e-07	4.13e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ACHE—kidney cancer	7.95e-07	4.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LDHB—kidney cancer	7.84e-07	4.07e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—POMC—kidney cancer	7.62e-07	3.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SCARB1—kidney cancer	7.53e-07	3.91e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—POMC—kidney cancer	7.52e-07	3.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—kidney cancer	7.52e-07	3.91e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ACHE—kidney cancer	7.49e-07	3.89e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTT1—kidney cancer	7.49e-07	3.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS1—kidney cancer	7.45e-07	3.87e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—RAF1—kidney cancer	7.41e-07	3.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERBB2—kidney cancer	7.33e-07	3.81e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMD7—kidney cancer	7.31e-07	3.79e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTOR—kidney cancer	7.23e-07	3.76e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—kidney cancer	7.22e-07	3.75e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—kidney cancer	7.17e-07	3.72e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SCARB1—kidney cancer	7.09e-07	3.68e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS1—kidney cancer	7.02e-07	3.65e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—kidney cancer	7e-07	3.64e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—kidney cancer	6.97e-07	3.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—BCHE—kidney cancer	6.93e-07	3.6e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMD7—kidney cancer	6.89e-07	3.58e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A5—kidney cancer	6.84e-07	3.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CA9—kidney cancer	6.8e-07	3.53e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—kidney cancer	6.79e-07	3.52e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK1—kidney cancer	6.66e-07	3.46e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC2A1—kidney cancer	6.61e-07	3.43e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—POMC—kidney cancer	6.55e-07	3.4e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—BCHE—kidney cancer	6.53e-07	3.39e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.45e-07	3.35e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CTNNB1—kidney cancer	6.41e-07	3.33e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.3e-07	3.27e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—kidney cancer	6.29e-07	3.27e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RAF1—kidney cancer	6.28e-07	3.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RELA—kidney cancer	6.25e-07	3.25e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—kidney cancer	6.25e-07	3.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.23e-07	3.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB2—kidney cancer	6.22e-07	3.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MTOR—kidney cancer	6.13e-07	3.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—kidney cancer	6e-07	3.12e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—kidney cancer	5.78e-07	3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CRABP1—kidney cancer	5.78e-07	3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—kidney cancer	5.76e-07	2.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—kidney cancer	5.63e-07	2.93e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTP1—kidney cancer	5.51e-07	2.86e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—kidney cancer	5.49e-07	2.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CTNNB1—kidney cancer	5.44e-07	2.82e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.37e-07	2.79e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—kidney cancer	5.34e-07	2.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—kidney cancer	5.3e-07	2.75e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—kidney cancer	5.23e-07	2.72e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—kidney cancer	5.23e-07	2.71e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—kidney cancer	5.19e-07	2.7e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTP1—kidney cancer	5.19e-07	2.7e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK1—kidney cancer	5.08e-07	2.64e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—kidney cancer	5.06e-07	2.63e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCB1—kidney cancer	4.92e-07	2.55e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—kidney cancer	4.92e-07	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTT1—kidney cancer	4.9e-07	2.54e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACHE—kidney cancer	4.9e-07	2.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1A1—kidney cancer	4.8e-07	2.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—kidney cancer	4.8e-07	2.49e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—kidney cancer	4.79e-07	2.49e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—kidney cancer	4.77e-07	2.48e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.64e-07	2.41e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.59e-07	2.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—kidney cancer	4.56e-07	2.37e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—kidney cancer	4.53e-07	2.35e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.52e-07	2.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.5e-07	2.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—kidney cancer	4.41e-07	2.29e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—kidney cancer	4.4e-07	2.29e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK1—kidney cancer	4.31e-07	2.24e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—BCHE—kidney cancer	4.27e-07	2.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.22e-07	2.19e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.07e-07	2.11e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—kidney cancer	4.07e-07	2.11e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—kidney cancer	3.74e-07	1.94e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—kidney cancer	3.69e-07	1.92e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—kidney cancer	3.62e-07	1.88e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—POMC—kidney cancer	3.58e-07	1.86e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.4e-07	1.76e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—POMC—kidney cancer	3.37e-07	1.75e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—kidney cancer	3.22e-07	1.67e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.21e-07	1.67e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.12e-07	1.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.96e-07	1.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—kidney cancer	2.86e-07	1.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.69e-07	1.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—kidney cancer	2.49e-07	1.29e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—kidney cancer	2.35e-07	1.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—POMC—kidney cancer	2.21e-07	1.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.76e-07	9.14e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.76e-07	9.12e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.66e-07	8.6e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—kidney cancer	1.53e-07	7.97e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.08e-07	5.62e-06	CbGpPWpGaD
